In colon cancer, normal colon tissue and blood cells have altered telomere lengths

Journal of Surgical Oncology

Volumn 111, Issue 7, 2015, Pages 899-904

  Valls Bautista, Cristina ^a,b   Piñol Felis, Carme ^a,b   Reñé Espinet, Josep M ^a,b,c   Buenestado García, Juan ^a,b,c   Viñas Salas, Joan ^b,c,d  

^a UNIVERSITY OF LLEIDA   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

^c HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^d Universitat de Lleida Facultat de Medicina Sabadell   (Spain)

Author keywords

colorectal cancer; telomere behaviour; telomere length; telomere length in blood cells

Indexed keywords

DNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD CELL; CLINICAL ARTICLE; COLON CANCER; COLON MUCOSA; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SOUTHERN BLOTTING; TELOMERE; TELOMERE LENGTH; BLOOD; CANCER STAGING; CASE CONTROL STUDY; COLON; COLORECTAL TUMOR; COMPARATIVE STUDY; FOLLOW UP; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TELOMERE HOMEOSTASIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD CELLS; CASE-CONTROL STUDIES; COLON; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TELOMERE HOMEOSTASIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84928824370     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23894     Document Type: Article

References (39)

1. Blackburn EH,: Structure and function of telomeres. Nature 1991; 350: 569-573.
2. Autexier C, Greider CW,: Telomerase and cancer: Revisiting the telomere hypothesis. Trends Biochem Sci. 1996; 21: 387-391.
3. Cong YS, Wright WE, Shay JW,: Human telomerase and its regulation. Microbiol Mol Biol Rev 2002; 66: 407-425.
4. Hug N, Lingner J,: Telomere length homeostasis. Chromosoma 2006; 115: 413-425.
5. Richter T, von Zglinicki T,: A continuous correlation between oxidative stress and telomere shortening in fibroblasts. Exp Gerontol 2007; 42: 1039-1042.
6. Smogorzewska A, de Lange T,: Regulation of telomerase by telomeric proteins. Annu Rev Biochem 2004; 73: 177-208.
7. Brunori M, Lucinao P, Gilson E, et al.: The telomerase cycle: Normal and pathological aspects. J Mol Med 2005; 83: 244-257.
8. Meeker AK, Hicks JL, Iacobuzio-Donahue CA,: Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 2004; 10: 3317-3326.
9. Rudolph KL, Millard M, Bosenberg MW, et al.: Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 2001; 28: 155-159.
10. Garcia-Aranda C, de Juan C, Diaz-Lopez, et al.: Correlations of telomeres length, telomerase activity and telomeric-repeat binding factor 1 expression in colorectal carcinoma Cancer 2006; 106: 541-551
11. Engelhardt M, Drullisnky P, Guillem J,: Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 1997; 122: 1141-1145.
12. Gertler R, Rosenberg R, Stricker D, et al.: Telomere length and human telomerase reserve transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol 2004; 22: 1807-1814.
13. Kim HR, Kim YJ, Kim HJ, et al.: Telomere length changes in colorectal cancer and polyps. J Korean Med Sci 2002; 17: 360-365.
14. Nakamura K, Furugori E, Esaki Y, et al.: Correlation of telomere lengths in normal and cancer tissue in the large bowel. Cancer Lett 2000; 158: 179-184.
15. Valls C, Piñol C, Reñé JM, et al.: Telomere length is a prognostic factor for overall survival in colorectal cancer. Colorectal Dis 2011; 13: 1265-1272.
16. Ohali A, Avigad S, Ash S, et al.: Telomere length is a prognostic factor in neuroblastoma. Cancer 2006; 107: 1391-1399.
17. Kammori M, Tabuko K, Nakamura K, et al.: Telomerase activity and telomere length in benign and malignant human thyroid tissue. Cancer Lett 2000; 159: 175-181.
18. Odagiri E, Kanada N, Jibiki K, et al.: Reduction of telomere length and c-erbB-2 gene amplification in human breast cancer fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters. Cancer 1994; 73: 2978-2984.
19. Shirotani Y, Hiyama K, Ishioka S, et al.: Alteration in length of telomeric repeats in lung cancer. Lung Cancer 1994; 11: 29-41.
20. Meeker AK, Hicks JL, Platz EA, et al.: Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res 2002; 62: 6405-6409.
21. van Heek NT, Meeker AK, Kern SE, et al.: Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol 2002; 161: 1541-1547.
22. Bissell MJ, Kenny PA, Radisky DC,: Microenviromental regulators of tissue structure and function also regulate tumor induction and progression: The role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol 2005; 70: 343-356.
23. Elwood N,: Telomere biology of human hematopoietic stem cells. Cancer Control 2004; 11: 77-85. Review.
24. Risques RA, Lai LA, Brentnall TA, et al.: Ulcerative colitis is a disease of accelerated colon aging: Evidence from telomere attrition and DNA damage. Gastroenterology 2008; 135: 410-418. doi: 10.1053/j.gastro.2008.04.008
25. Rampazzo E, Bertorelle R, Serra L, et al.: Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers. Br J Cancer 2010; 102: 1300-1305. doi: 10.1038/sj.bjc.6605644
26. Iacopetta B,: Are there two sides to colorectal cancer? Int J Cancer 2002; 101: 403-408. Review.
27. Roger L, Jones RE, Heppel NH, et al.: Extensive telomere erosion in the initiation of colorectal adenomas and its association with chromosomal instability. J Natl Cancer Inst 2013; 105: 1202-1211. doi: 10.1093/jnci/djt191
28. Valls Bautista C, Piñol Felis C, Reñé Espinet JM, et al.: Telomerase activity and telomere length in the colorectal polyp-carcinoma sequence. Rev Esp Enferm Dig 2009; 101: 179-186.
29. Shay JW,: Determining if telomeres matter in colon cancer initiation or progression. J Natl Cancer Inst 2013; 105: 1166-1168 doi: 10.1093/jnci/djt200
30. Pellatt AJ, Wolff RK, Lundgreen A, et al.: Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study. Int J Mol Epidemiol Genet 2012; 3: 184-194.
31. Friedrich U, Griese E, Schwab M, et al.: Telomere length in different tissues of elderly patients. Mech Ageing Dev 2000; 119: 89-99.
32. Hastie ND, Dempster M, Dunlop MG, et al.: Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990; 346: 866-868.
33. Allsopp RC, Vaziri H, Patterson C, et al.: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1998; 95: 5607-5610.
34. O'Sullivan J, Risques RA, Mandelson MT, et al.: Telomere length in the colon declines with age: A relation to colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 573-577.
35. Shao L, Wood CG, Zhang D, et al.: Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J Urol 2007; 178: 1492-1496.
36. Wu X, Amos CI, Zhu Y, et al.: Telomere dysfunction: A potential cancer predisposition factor. J Natl Cancer Inst 2003; 95: 1211-1218.
37. Weischer M, Nordestgaard BG, Cawthon RM, et al.: Short telomere length, cancer survival, and cancer risk in 47102 individuals. J Natl Cancer Inst 2013; 105: 459-468. doi: 10.1093/jnci/djt016. Epub 2013 Mar 6.
38. Risques RA, Vaughan TL, Li X, et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007; 16: 265-2649.
39. Kaszubowska L, Telomere shortening and ageing of the immune system. J Physiol Pharmacol 2008; 59: 169-186. Review.